mRNA Vaccines and Therapeutics Market Size, Share, Trends and Forecast by Vaccine Type, Treatment Type, Vaccine Manufacturing, Application, End-User, and Region 2026-2034

mRNA Vaccines and Therapeutics Market Size, Share, Trends and Forecast by Vaccine Type, Treatment Type, Vaccine Manufacturing, Application, End-User, and Region 2026-2034

Report Format: PDF+Excel | Report ID: SR112026A2207

1   Preface
2   Scope and Methodology 
    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Introduction
    4.1    Overview
    4.2    Key Industry Trends
5   Introduction to mRNA Vaccines and Therapeutics
    5.1    History of mRNA Vaccines and Therapeutics Development
    5.2    Incidence and Prevalence of Chronic Diseases and Major Infectious Diseases
    5.3    Prevention and Treatment Using mRNA Vaccines and Therapeutics
        5.3.1 mRNA Modifications
        5.3.2 mRNA Efficiencies
        5.3.3 Adjuvant/Stimulant and Carrier Technologies for mRNA-Based Vaccines
        5.3.4 Carriers for mRNA-Based Protein and Antibody Therapeutics
6   Global mRNA Vaccines and Therapeutics Market
    6.1 Market Potential Overview
    6.2 Market Potential
    6.3 Impact of COVID-19
    6.4 mRNA Vaccines in Pipeline
7   Market Breakup by Vaccine Type
    7.1 Self-amplifying mRNA-Based Vaccines
    7.2 Conventional Non-Amplifying mRNA-Based Vaccines
8   Market Breakup by Treatment Type
    8.1 Gene Therapy
    8.2 Monoclonal Antibody
    8.3 Gene Transcription 
    8.4 Cell Therapy
    8.5 Bioengineered Vaccine
    8.6 Others
9   Market Breakup by Vaccine Manufacturing
    9.1 In-House
    9.2 Out-Sourced
10   Market Breakup by Application
     10.1 Cancer
     10.2 Infectious Disease
     10.3 Gene Editing
     10.4 Protein Replacement
11   Market Breakup by End-User
     11.1 Hospitals and Clinics
     11.2 Research Organizations
     11.3 Others
12   Market Breakup by Region
     12.1 North America
       12.1.1 Market Breakup by Country
         12.1.1.1 United States
         12.1.1.2 Canada
     12.2 Europe
       12.2.1 Market Breakup by Country
         12.2.1.1 Germany
         12.2.1.2 United Kingdom
         12.2.1.3 France
         12.2.1.4 Italy
         12.2.1.5 Spain
         12.2.1.6 Russia
         12.2.1.7 Others
     12.3 Asia Pacific
       12.3.1 Market Breakup by Country
         12.3.1.1 Japan
         12.3.1.2 China
         12.3.1.3 Australia
         12.3.1.4 South Korea
         12.3.1.5 India
         12.3.1.6 Indonesia
         12.3.1.7 Others
    12.4 Latin America
       12.4.1 Market Breakup by Country
         12.4.1.1 Brazil
         12.4.1.2 Mexico
         12.4.1.3 Others
    12.5 Middle East and Africa
       12.5.1 Market Breakup by Country
13  SWOT Analysis
    13.1    Overview
    13.2    Strengths
    13.3    Weaknesses
    13.4    Opportunities
    13.5    Threats
14  Value Chain Analysis
15  Porters Five Forces Analysis
    15.1    Overview
    15.2    Bargaining Power of Buyers
    15.3    Bargaining Power of Suppliers
    15.4    Degree of Competition
    15.5    Threat of New Entrants
    15.6    Threat of Substitutes
16  Competitive Landscape
    16.1    Market Structure
    16.2    Key Players
    16.3    Profiles of Key Players
        16.3.1  Moderna, Inc.
           16.3.1.1 Business Overview
           16.3.1.2 Products Offered
           16.3.1.3 Business Strategies
           16.3.1.4 SWOT Analysis
           16.3.1.5 Major News and Events
        16.3.2   BioNTech SE
           16.3.2.1 Business Overview
           16.3.2.2 Products Offered
           16.3.2.3 Business Strategies
           16.3.2.4 SWOT Analysis
           16.3.2.5 Major News and Events
        16.3.3    Pfizer Inc.
           16.3.3.1 Business Overview
           16.3.3.2 Products Offered
           16.3.3.3 Business Strategies
           16.3.3.4 SWOT Analysis
           16.3.3.5 Major News and Events
        16.3.4    GSK plc
           16.3.4.1 Business Overview
           16.3.4.2 Products Offered
           16.3.4.3 Business Strategies
           16.3.4.4 SWOT Analysis
           16.3.4.5 Major News and Events
        16.3.5    Arcturus Therapeutics
           16.3.5.1 Business Overview
           16.3.5.2 Products Offered
           16.3.5.3 Business Strategies
           16.3.5.4 SWOT Analysis
           16.3.5.5 Major News and Events
        16.3.6    Sanofi
           16.3.6.1 Business Overview
           16.3.6.2 Products Offered
           16.3.6.3 Business Strategies
           16.3.6.4 SWOT Analysis
           16.3.6.5 Major News and Events
        16.3.7    Merck & Co.
           16.3.7.1 Business Overview
           16.3.7.2 Products Offered
           16.3.7.3 Business Strategies
           16.3.7.4 SWOT Analysis
           16.3.7.5 Major News and Events

List of Figures

Figure 1: Global: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Billion USD), 2026-2034
Figure 2: Global: mRNA Vaccines and Therapeutics Market Potential (Self-amplifying mRNA-Based Vaccines): Value Trends (in Billion USD), 2026-2034
Figure 3: Global: mRNA Vaccines and Therapeutics Market Potential (Conventional Non-Amplifying mRNA-Based Vaccines): Value Trends (in Billion USD), 2026-2034
Figure 4: Global: mRNA Vaccines and Therapeutics Market Potential (Gene Therapy): Value Trends (in Billion USD), 2026-2034
Figure 5: Global: mRNA Vaccines and Therapeutics Market Potential (Monoclonal Antibody): Value Trends (in Billion USD), 2026-2034
Figure 6: Global: mRNA Vaccines and Therapeutics Market Potential (Gene Transcription): Value Trends (in Billion USD), 2026-2034
Figure 7: Global: mRNA Vaccines and Therapeutics Market Potential (Cell Therapy): Value Trends (in Billion USD), 2026-2034
Figure 8: Global: mRNA Vaccines and Therapeutics Market Potential (Bioengineered Vaccine): Value Trends (in Billion USD), 2026-2034
Figure 9: Global: mRNA Vaccines and Therapeutics Market Potential (Other Treatment Types): Value Trends (in Billion USD), 2026-2034
Figure 10: Global: mRNA Vaccines and Therapeutics Market Potential (In-House): Value Trends (in Billion USD), 2026-2034
Figure 11: Global: mRNA Vaccines and Therapeutics Market Potential (Out-Sourced): Value Trends (in Billion USD), 2026-2034
Figure 12: Global: mRNA Vaccines and Therapeutics Market Potential (Cancer): Value Trends (in Billion USD), 2026-2034
Figure 13: Global: mRNA Vaccines and Therapeutics Market Potential (Infectious Disease): Value Trends (in Billion USD), 2026-2034
Figure 14: Global: mRNA Vaccines and Therapeutics Market Potential (Gene Editing): Value Trends (in Billion USD), 2026-2034
Figure 15: Global: mRNA Vaccines and Therapeutics Market Potential (Protein Replacement): Value Trends (in Billion USD), 2026-2034
Figure 16: Global: mRNA Vaccines and Therapeutics Market Potential (Hospitals and Clinics): Value Trends (in Billion USD), 2026-2034
Figure 17: Global: mRNA Vaccines and Therapeutics Market Potential (Research Organizations): Value Trends (in Billion USD), 2026-2034
Figure 18: Global: mRNA Vaccines and Therapeutics Market Potential (Other End-Users): Value Trends (in Billion USD), 2026-2034
Figure 19: North America: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Billion USD), 2026-2034
Figure 20: North America: mRNA Vaccines and Therapeutics Market Potential: Breakup by Country (in %), 2025
Figure 21: United States: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Million USD), 2026-2034
Figure 22: Canada: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Million USD), 2026-2034
Figure 23: Europe: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Billion USD), 2026-2034
Figure 24: Europe: mRNA Vaccines and Therapeutics Market Potential: Breakup by Country (in %), 2025
Figure 25: Germany: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Million USD), 2026-2034
Figure 26: United Kingdom: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Million USD), 2026-2034
Figure 27: France: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Million USD), 2026-2034
Figure 28: Italy: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Million USD), 2026-2034
Figure 29: Spain: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Million USD), 2026-2034
Figure 30: Russia: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Million USD), 2026-2034
Figure 31: Others: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Million USD), 2026-2034
Figure 32: Asia Pacific: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Billion USD), 2026-2034
Figure 33: Asia Pacific: mRNA Vaccines and Therapeutics Market Potential: Breakup by Country (in %), 2025
Figure 34: Japan: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Million USD), 2026-2034
Figure 35: China: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Million USD), 2026-2034
Figure 36: Australia: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Million USD), 2026-2034
Figure 37: South Korea: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Million USD), 2026-2034
Figure 38: India: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Million USD), 2026-2034
Figure 39: Indonesia: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Million USD), 2026-2034
Figure 40: Others: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Million USD), 2026-2034
Figure 41: Latin America: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Billion USD), 2026-2034
Figure 42: Latin America: mRNA Vaccines and Therapeutics Market Potential: Breakup by Country (in %), 2025
Figure 43: Brazil: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Million USD), 2026-2034
Figure 44: Mexico: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Million USD), 2026-2034
Figure 45: Others: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Million USD), 2026-2034
Figure 46: Middle East and Africa: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Billion USD), 2026-2034
Figure 47: Middle East and Africa: mRNA Vaccines and Therapeutics Market Potential: Breakup by Country (in %), 2025
Figure 48: Global: mRNA Vaccines and Therapeutics Industry: SWOT Analysis
Figure 49: Global: mRNA Vaccines and Therapeutics Industry: Value Chain Analysis
Figure 50: Global: mRNA Vaccines and Therapeutics Industry: Porter’s Five Forces Analysis

List of Tables

Table 1: Global: mRNA Vaccines and Therapeutics Market Potential: Key Industry Highlights, 2025 and 2034
Table 2: Global: mRNA Vaccines and Therapeutics Market: List of Pipeline mRNA Vaccines
Table 3: Global: mRNA Vaccines and Therapeutics Market Potential: Breakup by Vaccine Type (in Billion USD), 2026-2034
Table 4: Global: mRNA Vaccines and Therapeutics Market Potential: Breakup by Treatment Type (in Billion USD), 2026-2034
Table 5: Global: mRNA Vaccines and Therapeutics Market Potential: Breakup by Vaccine Manufacturing (in Billion USD), 2026-2034
Table 6: Global: mRNA Vaccines and Therapeutics Market Potential: Breakup by Application (in Billion USD), 2026-2034
Table 7: Global: mRNA Vaccines and Therapeutics Market Potential: Breakup by End-User (in Billion USD), 2026-2034
Table 8: Global: mRNA Vaccines and Therapeutics Market Potential: Breakup by Region (in Billion USD), 2026-2034
Table 9: Global: mRNA Vaccines and Therapeutics Market: Competitive Structure
Table 10: Global: mRNA Vaccines and Therapeutics Market: List of Key Players

mRNA Vaccines and Therapeutics Market Size, Share, Trends and Forecast by Vaccine Type, Treatment Type, Vaccine Manufacturing, Application, End-User, and Region 2026-2034
Purchase Options Discount
Offer
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-201-971-6302

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials